SCZ is conceptualized as an illness of dopaminergic dysfunction, links to abnormal metabolism (particularly type II DM), and may share plausible overlaps with CNS insulin dysregulation because of premorbid cognitive deficits (9). The gene discussed is INS; the disease is Cognitive impairment.